View Financial HealthElevra Lithium 配当と自社株買い配当金 基準チェック /06Elevra Lithium配当金を支払った記録がありません。主要情報n/a配当利回り-2.4%バイバック利回り総株主利回り-2.4%将来の配当利回り0%配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 15Elevra Lithium Limited has completed a Follow-on Equity Offering in the amount of AUD 275.000005 million.Elevra Lithium Limited has completed a Follow-on Equity Offering in the amount of AUD 275.000005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,540,984 Price\Range: AUD 12.2 Discount Per Security: AUD 0.366 Transaction Features: Subsequent Direct Listingお知らせ • May 13+ 1 more updateElevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 275.000005 million.Elevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 275.000005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,540,984 Price\Range: AUD 12.2 Discount Per Security: AUD 0.2928 Transaction Features: Subsequent Direct Listingお知らせ • May 12Elevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 19.999997 million.Elevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 19.999997 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,639,344 Price\Range: AUD 12.2お知らせ • Apr 15Elevra Lithium Limited to Report Q3, 2026 Results on Apr 23, 2026Elevra Lithium Limited announced that they will report Q3, 2026 results on Apr 23, 2026お知らせ • Feb 25Elevra Lithium Limited Confirms Production Guidance for 2026Elevra Lithium Limited confirmed production guidance for the year 2026 . The Company confirmed that its previously issued guidance, as announced on 28 January 2026, remains unchanged. For the relevant period, spodumene concentrate production is expected to be in the range of 180,000 to 190,000 dry metric tonnes (dmt), while spodumene concentrate sales are projected between 170,000 and 190,000 dmt.お知らせ • Feb 20Elevra Lithium Limited to Report First Half, 2026 Results on Feb 25, 2026Elevra Lithium Limited announced that they will report first half, 2026 results on Feb 25, 2026お知らせ • Jan 29Elevra Lithium Limited Revises Production Guidance and for the Fiscal Year 2026Elevra Lithium Limited revised production guidance and for the fiscal year 2026. For the year, the company now expects Spodumene concentrate production of 180,000-190,000 dmt compared to previous guidance of 195,000 –210,000 dmt.お知らせ • Jan 22Elevra Lithium Limited to Report Q2, 2026 Results on Jan 28, 2026Elevra Lithium Limited announced that they will report Q2, 2026 results on Jan 28, 2026お知らせ • Oct 21Elevra Lithium Limited to Report Q1, 2026 Results on Oct 29, 2025Elevra Lithium Limited announced that they will report Q1, 2026 results on Oct 29, 2025お知らせ • Oct 20Elevra Lithium Limited Announces CFO Changes, with Effect from 20 October 2025Elevra Lithium Limited announced the resignation of Mr. Dougal Elder as Chief Financial Officer and the appointment of Mr. Christian Cortes as Chief Financial Officer for the Company. In accordance with Listing Rule 3.16, Elevra advises that Mr. Dougal Elder has resigned as the Company's Chief Financial Officer (CFO) and that the Company has appointed Mr. Christian Cortes as the Company's CFO with effect from 20 October 2025. Mr. Elder advised the Company of his decision to leave Elevra to pursue other opportunities. Mr. Elder will remain with the Company for a period of 3 months to facilitate the handover of duties to Mr. Cortes and to ensure business continuity during this period. Mr. Christian Cortes was recently Arcadium Lithium's Chief Integration and Transformation Officer up to the time of Rio Tinto's business acquisition. Prior to that, Christian served as the Chief of Sales and Marketing and then as Chief Financial Officer of Allkem Limited prior to its merger with Livent Corporation. Christian brings 20 years of international business experience in the professional services and resources industries. Christian began his career as a Chartered Accountant with PwC, working with public companies in audit and transaction support.決済の安定と成長配当データの取得安定した配当: DML1の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: DML1の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Elevra Lithium 配当利回り対市場DML1 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (DML1)n/a市場下位25% (DE)1.5%市場トップ25% (DE)4.5%業界平均 (Metals and Mining)1.4%アナリスト予想 (DML1) (最長3年)0%注目すべき配当: DML1は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: DML1は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: DML1の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: DML1が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 22:10終値2026/05/22 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Elevra Lithium Limited 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Raj RayBMO Capital Markets Equity ResearchReg SpencerCanaccord GenuityAndrey LitvinEdison Investment Research1 その他のアナリストを表示
お知らせ • May 15Elevra Lithium Limited has completed a Follow-on Equity Offering in the amount of AUD 275.000005 million.Elevra Lithium Limited has completed a Follow-on Equity Offering in the amount of AUD 275.000005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,540,984 Price\Range: AUD 12.2 Discount Per Security: AUD 0.366 Transaction Features: Subsequent Direct Listing
お知らせ • May 13+ 1 more updateElevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 275.000005 million.Elevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 275.000005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,540,984 Price\Range: AUD 12.2 Discount Per Security: AUD 0.2928 Transaction Features: Subsequent Direct Listing
お知らせ • May 12Elevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 19.999997 million.Elevra Lithium Limited has filed a Follow-on Equity Offering in the amount of AUD 19.999997 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,639,344 Price\Range: AUD 12.2
お知らせ • Apr 15Elevra Lithium Limited to Report Q3, 2026 Results on Apr 23, 2026Elevra Lithium Limited announced that they will report Q3, 2026 results on Apr 23, 2026
お知らせ • Feb 25Elevra Lithium Limited Confirms Production Guidance for 2026Elevra Lithium Limited confirmed production guidance for the year 2026 . The Company confirmed that its previously issued guidance, as announced on 28 January 2026, remains unchanged. For the relevant period, spodumene concentrate production is expected to be in the range of 180,000 to 190,000 dry metric tonnes (dmt), while spodumene concentrate sales are projected between 170,000 and 190,000 dmt.
お知らせ • Feb 20Elevra Lithium Limited to Report First Half, 2026 Results on Feb 25, 2026Elevra Lithium Limited announced that they will report first half, 2026 results on Feb 25, 2026
お知らせ • Jan 29Elevra Lithium Limited Revises Production Guidance and for the Fiscal Year 2026Elevra Lithium Limited revised production guidance and for the fiscal year 2026. For the year, the company now expects Spodumene concentrate production of 180,000-190,000 dmt compared to previous guidance of 195,000 –210,000 dmt.
お知らせ • Jan 22Elevra Lithium Limited to Report Q2, 2026 Results on Jan 28, 2026Elevra Lithium Limited announced that they will report Q2, 2026 results on Jan 28, 2026
お知らせ • Oct 21Elevra Lithium Limited to Report Q1, 2026 Results on Oct 29, 2025Elevra Lithium Limited announced that they will report Q1, 2026 results on Oct 29, 2025
お知らせ • Oct 20Elevra Lithium Limited Announces CFO Changes, with Effect from 20 October 2025Elevra Lithium Limited announced the resignation of Mr. Dougal Elder as Chief Financial Officer and the appointment of Mr. Christian Cortes as Chief Financial Officer for the Company. In accordance with Listing Rule 3.16, Elevra advises that Mr. Dougal Elder has resigned as the Company's Chief Financial Officer (CFO) and that the Company has appointed Mr. Christian Cortes as the Company's CFO with effect from 20 October 2025. Mr. Elder advised the Company of his decision to leave Elevra to pursue other opportunities. Mr. Elder will remain with the Company for a period of 3 months to facilitate the handover of duties to Mr. Cortes and to ensure business continuity during this period. Mr. Christian Cortes was recently Arcadium Lithium's Chief Integration and Transformation Officer up to the time of Rio Tinto's business acquisition. Prior to that, Christian served as the Chief of Sales and Marketing and then as Chief Financial Officer of Allkem Limited prior to its merger with Livent Corporation. Christian brings 20 years of international business experience in the professional services and resources industries. Christian began his career as a Chartered Accountant with PwC, working with public companies in audit and transaction support.